Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Life Science seminar 2024

By HC Andersen Capital

Do you want to know more about the latest development in the Nordic Life Science industry? Get an update on HC Andersen Capital's view on valuation as well as presentations from listed Life Science companies take on their late-stage pipeline.

We are proud to present: Ascelia Pharma, Gubra, BioPorto, Pharma Equity Group and ExpreS2ion Biotechnologies.

Agenda
09.35-09.55 - Introduction
10.00-10.25 - Ascelia Pharma
10.30-10.55 - Gubra
11.00-11.25 - BioPorto
11.30-11.55 - Pharma Equity Group
12.00-12.25 - ExpreS2ion Biotechnologies

Disclaimer: HC Andersen Capital receives payment from Ascelia Pharma, Gubra, BioPorto, Pharma Equity Group and ExpreS2ion Biotechnologies. for a Digital IR/corporate visibility agreement./Mie Halse 14.05.2024 at 13.33.

Stay up to date
Ascelia Pharma
Gubra
BioPorto
Pharma Equity Group
ExpreS2ion Biotech Holding

Recent videos

Orion as an Investment | Life Science Night Dec. 9, 2025
13.12.2025 klo 13.50 Orion
A sit-down with CEO Remco Westermann
12.12.2025 klo 10.09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
11.12.2025 klo 12.00 Aiforia Technologies
Endomines as an Investment | Investor Day Nov. 24, 2025
10.12.2025 klo 13.30 Endomines Finland
Clas Ohlson, Audiocast, Q2'25
10.12.2025 klo 10.00 Clas Ohlson
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.